Login / Signup

PD-L1 (Programmed Death Ligand 1) Regulates T-Cell Differentiation to Control Adaptive Venous Remodeling.

Yutaka Matsubara (松原 裕)Luis GonzalezGathe KiwanJia Liu (刘 佳)John LangfordMingjie Gao (高 明杰)Xixiang Gao (高 喜翔)Ryosuke Taniguchi (谷口 良輔)Bogdan YatsulaTadashi Furuyama (古山 正)Takuya Matsumoto (松本 拓也)Kimihiro Komori (古森 公浩)Masaki Mori (森 正樹)Alan Dardik
Published in: Arteriosclerosis, thrombosis, and vascular biology (2021)
Regulation of PD-L1 activity may be a potential therapeutic target for clinical translation to improve AVF maturation.
Keyphrases
  • risk assessment